Yo-Health Inc.

CIK:0001844793|SEC Filings

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Condensed Consolidated Statements of Operations
Revenue	$ 2,500,311	$ 201,359	$ 5,718,680	$ 388,253
Cost of revenue	1,589,775	326,564	4,303,560	1,189,047
Gross profit (loss)	910,536	(125,204)	1,415,120	(800,793)
Operating Expenses
General and administrative expenses	1,725,370	3,411,220	5,442,108	8,856,872
Professional fees	54,723	54,605	254,278	159,341
Rent expense	57,007	62,938	193,259	166,490
Total operating expenses	1,837,100	3,528,763	5,889,645	9,182,703
Loss from operations	(926,564)	(3,653,967)	(4,474,525)	(9,983,497)
Other income(expense)
Interest expense	(25,718)	(11,290)	(95,869)	(34,024)
Interest income	0	1,817	0	1,817
Gain on the sale of building	0	0	438	0
Other expense, net	(25,718)	(9,472)	(95,431)	(32,207)
Loss before provision for income taxes	(952,282)	(3,663,439)	(4,569,957)	(10,015,704)
Provision (credit) for income tax	0	0	0	0
Loss from continuing operations	(952,282)	(3,663,439)	(4,569,957)	(10,015,704)
Income (loss) from discontinued operations	0	9,047	(107,180)	208,938
Net loss	$ (952,282)	$ (3,654,392)	$ (4,677,137)	$ (9,806,766)
Loss from continuing operations	$ (0.01)	$ (0.05)	$ (0.06)	$ (0.16)
Income (loss) from discontinued operations	$ 0	$ 0.00	$ (0.00)	$ 0.00
Weighted average number of shares outstanding	76,661,355	67,338,998	75,054,536	62,272,998

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net Cash Provided by (Used in) Operating Activities
Loss from continuing operations	$ (4,569,957)	$ (10,015,704)
Less: income (loss) from discontinued operations	(107,180)	208,938
Net loss	(4,677,137)	(9,806,766)
Stock based compensation	3,247,680	8,185,500
Depreciation	232,222	34,971
Gain on the sale of building	(438)
Changes in operating assets and liabilities
Accounts receivable	179,298	110,678
Accounts receivable other	0	7,400
Subscriptions receivable	0	20,000
Other assets	(5,430)	0
Security deposits	0	(6,700)
Accounts payable and accrued liabilities	175,305	50,926
Mortgage payable	(34,171)	106,611
Net cash used in operating activities -continuing operations	(882,670)	(1,297,380)
Net cash provided by (used in) operating activities -discontinued operations	0	0
Net cash (used in) operating activities	(882,670)	(1,297,380)
Cash flows from Investing Activities
Property and equipment -asset purchase	(49,289)	(410,312)
Cash flows (used in) investing activities	(49,289)	(410,312)
Cash Flows From Financing Activities
Proceeds from line of credit	423,000	0
Notes payable related parties	255,700	0
Proceeds from the sale of property	255,000	0
Proceeds from the sale of common stock	70,000	1,560,000
Net cash provided by investing activities	1,003,700	1,560,000
Net Increase (Decrease) In Cash	71,741	(147,692)
Cash At The Beginning Of The Period	124,062	1,429,587
Cash At The End Of The Period	$ 195,803	$ 1,281,895

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 195,803	$ 124,062
Accounts receivable	0	179,298
Total current assets	195,803	303,361
Property plant and equipment, net	3,442,091	4,017,136
Intangible assets	40,799	37,999
Right of use assets	900,422	776,405
Other assets	6,630	1,200
Security deposits	29,150	29,150
Total Assets	4,614,894	5,165,250
Current liabilities
Accounts payable and accrued expenses	225,944	59,233
Lease liabilities short term	204,116	188,113
Line of credit	484,490	61,490
Notes payable related parties	255,700	0
Total current liabilities	1,170,249	308,836
Long term lease liabilities	737,789	610,930
Mortgage liabilities	1,549,713	1,728,883
Total Liabilities	3,457,751	2,648,649
Shareholders' deficit:
Common stock, $0.0001 par value; 100,000,000 shares authorized, 77,226,355 and 70,590,898 outstanding as of September 30, 2023 and December 31 2022, respectively	7,723	7,059
Additional paid-in capital	20,301,605	16,984,590
Accumulated deficit	(19,152,185)	(14,475,048)
Total shareholders' deficit	1,157,143	2,516,601
Total liabilities and shareholders' deficit	$ 4,614,894	$ 5,165,250